• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于厚脉络膜/ 玻璃膜疣视角的老年黄斑新生血管的细胞因子特征。

Cytokine profiles of macular neovascularization in the elderly based on a classification from a pachychoroid/drusen perspective.

机构信息

Department of Ophthalmology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi, 329-0431, Japan.

Department of Ophthalmology Japan Community Healthcare Organization, Tokyo Shinjuku Medical Center, Shinjuku-ku, Tokyo, Japan.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2022 Mar;260(3):747-758. doi: 10.1007/s00417-021-05445-0. Epub 2021 Oct 29.

DOI:10.1007/s00417-021-05445-0
PMID:34714383
Abstract

PURPOSE

To classify macular neovascularization (MNV) based on pachychoroid and drusen features and to examine the aqueous humor cytokine signatures of each group.

METHODS

In total, 106 consecutive eyes with treatment-naïve MNV and 104 control eyes were examined. The aqueous humor concentrations of 15 cytokines were compared among the MNV groups classified based on the presence of drusen and/or pachychoroid features. Multidimensional scaling analysis was used to visualize the similarity level of the MNV subtypes according to their cytokine profiles.

RESULTS

Thirty-one, 18, 43, and 10 eyes were classified into the pachychoroid-associated, drusen-associated, pachychoroid/drusen-associated, and non-drusen/non-pachychoroid MNV groups, respectively. Compared with the control group, cytokines were differently upregulated among the MNV groups. CRP and CXCL12 were significantly upregulated in all MNV groups, whereas CXCL13 and IL-8 were significantly upregulated in three MNV groups, excluding the non-pachychoroid/non-drusen-associated MNV group. Ang-2 was significantly upregulated in three MNV groups except the drusen-associated MNV group. PlGF was significantly upregulated in the pachychoroid-associated and drusen-associated MNV groups. CCL-2 was significantly upregulated in the pachychoroid-associated and pachychoroid/drusen-associated MNV groups. VEGF was downregulated in the pachychoroid-associated and drusen-associated MNV groups, respectively. Multidimensional scaling analysis showed a distinct cytokine profile for each MNV group.

CONCLUSION

All MNV groups showed distinct cytokine profiles. Eyes with "neovascular age-related macular degeneration with drusen and concomitant pachychoroid" may share a similar etiology to those with "pachychoroid neovasculopathy" and "choroidal neovascularization with drusen," but have a distinct etiology to those without these. These findings suggest the importance of evaluating drusen and the choroid during the diagnosis of neovascular age-related macular degeneration.

摘要

目的

基于脉络膜增厚和玻璃膜疣特征对黄斑新生血管(MNV)进行分类,并研究各组房水细胞因子特征。

方法

共纳入 106 例未经治疗的 MNV 患眼和 104 例对照眼。比较基于玻璃膜疣和/或脉络膜增厚特征分类的 MNV 组之间房水中 15 种细胞因子的浓度。多维尺度分析用于根据 MNV 亚型的细胞因子谱来可视化其相似性水平。

结果

31、18、43 和 10 只眼分别被归类为脉络膜增厚相关、玻璃膜疣相关、脉络膜增厚/玻璃膜疣相关和非玻璃膜疣/非脉络膜增厚相关 MNV 组。与对照组相比,MNV 各组中的细胞因子水平存在差异上调。CRP 和 CXCL12 在所有 MNV 组中均显著上调,而 CXCL13 和 IL-8 在除非玻璃膜疣/非脉络膜增厚相关 MNV 组之外的三组 MNV 中显著上调。Ang-2 在除玻璃膜疣相关 MNV 组之外的三组 MNV 中显著上调。PlGF 在脉络膜增厚相关和玻璃膜疣相关 MNV 组中显著上调。CCL-2 在脉络膜增厚相关和脉络膜增厚/玻璃膜疣相关 MNV 组中显著上调。VEGF 在脉络膜增厚相关和玻璃膜疣相关 MNV 组中分别下调。多维尺度分析显示每个 MNV 组都有独特的细胞因子谱。

结论

所有 MNV 组均显示出独特的细胞因子谱。具有“玻璃膜疣伴脉络膜增厚的新生血管性年龄相关性黄斑变性”的眼可能与“脉络膜新生血管病”和“伴玻璃膜疣的脉络膜新生血管”具有相似的病因,但与不具有这些特征的眼有不同的病因。这些发现提示在诊断新生血管性年龄相关性黄斑变性时评估玻璃膜疣和脉络膜的重要性。

相似文献

1
Cytokine profiles of macular neovascularization in the elderly based on a classification from a pachychoroid/drusen perspective.基于厚脉络膜/ 玻璃膜疣视角的老年黄斑新生血管的细胞因子特征。
Graefes Arch Clin Exp Ophthalmol. 2022 Mar;260(3):747-758. doi: 10.1007/s00417-021-05445-0. Epub 2021 Oct 29.
2
Clinical characteristics and pachychoroid incidence in Japanese patients with neovascular age-related macular degeneration.日本新生血管性年龄相关性黄斑变性患者的临床特征及脉络膜增厚发生率。
Sci Rep. 2022 Mar 16;12(1):4492. doi: 10.1038/s41598-022-08666-3.
3
Qualitative and quantitative comparisons of type 1 macular neovascularizations between pachychoroid neovasculopathy and neovascular age-related macular degeneration using optical coherence tomography angiography.应用光相干断层扫描血管造影术对厚脉络膜新生血管与新生血管性年龄相关性黄斑变性 1 型黄斑新生血管进行定性和定量比较。
Eye (Lond). 2024 Jun;38(9):1714-1721. doi: 10.1038/s41433-024-03007-2. Epub 2024 Mar 12.
4
Intraocular Vascular Endothelial Growth Factor Levels in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.肥厚性脉络膜新生血管病变和新生血管性年龄相关性黄斑变性中的眼内血管内皮生长因子水平
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):292-298. doi: 10.1167/iovs.16-20967.
5
LONGITUDINAL ASSESSMENT OF CHOROIDAL STRUCTURE IN PATIENTS WITH MACULAR NEOVASCULARIZATION.脉络膜新生血管患者脉络膜结构的纵向评估。
Retina. 2022 Nov 1;42(11):2083-2090. doi: 10.1097/IAE.0000000000003580.
6
Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.补体激活产物和细胞因子在肥厚脉络膜新生血管病变和新生血管性年龄相关性黄斑变性中的作用。
Invest Ophthalmol Vis Sci. 2020 Nov 2;61(13):39. doi: 10.1167/iovs.61.13.39.
7
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration.年龄相关性黄斑变性中2型黄斑新生血管的玻璃膜疣特征
BMC Ophthalmol. 2020 Sep 25;20(1):381. doi: 10.1186/s12886-020-01651-2.
8
Comparison of Regional Differences in the Choroidal Thickness between Patients with Pachychoroid Neovasculopathy and Classic Exudative Age-related Macular Degeneration.厚脉络膜新生血管病变患者与典型渗出性年龄相关性黄斑变性患者脉络膜厚度的区域差异比较。
Curr Eye Res. 2021 Sep;46(9):1398-1405. doi: 10.1080/02713683.2021.1887269. Epub 2021 Feb 23.
9
Hyperreflective material in patients with non-neovascular pachychoroid disease.患有非新生血管性脉络膜肥厚症患者的高反射物质。
BMC Ophthalmol. 2023 Jun 6;23(1):255. doi: 10.1186/s12886-023-03011-2.
10
Pachychoroid neovasculopathy: a type-1 choroidal neovascularization belonging to the pachychoroid spectrum-pathogenesis, imaging and available treatment options.厚脉络膜新生血管病变:一种属于厚脉络膜谱系的1型脉络膜新生血管病变——发病机制、影像学及现有治疗选择
Int Ophthalmol. 2020 Dec;40(12):3577-3589. doi: 10.1007/s10792-020-01522-1. Epub 2020 Jul 30.

引用本文的文献

1
One-year outcomes of three-monthly and four-monthly loading regimens of faricimab for treatment-naïve neovascular age-related macular degeneration.法西单抗每三个月和每四个月给药方案用于初治新生血管性年龄相关性黄斑变性的一年疗效
Graefes Arch Clin Exp Ophthalmol. 2025 Aug 9. doi: 10.1007/s00417-025-06930-6.
2
Aqueous humor cytokine profile in insufficient responder to aflibercept for neovascular age-related macular degeneration.阿柏西普治疗新生血管性年龄相关性黄斑变性疗效不佳者的房水细胞因子谱
Int Ophthalmol. 2025 Aug 9;45(1):326. doi: 10.1007/s10792-025-03678-0.
3
Initial Response After Switching to Aflibercept 8 mg for Neovascular Age-Related Macular Degeneration.

本文引用的文献

1
Pachychoroid disease: a new perspective on exudative maculopathy.脉络膜增厚性疾病:渗出性黄斑病变的新视角。
Jpn J Ophthalmol. 2020 Jul;64(4):323-337. doi: 10.1007/s10384-020-00740-5. Epub 2020 Apr 21.
2
Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration.渗出型年龄相关性黄斑变性患者的盘状硬性渗出的临床和遗传学特征。
Sci Rep. 2019 Aug 15;9(1):11906. doi: 10.1038/s41598-019-48494-6.
3
Pachychoroid Geographic Atrophy: Clinical and Genetic Characteristics.厚脉络膜性地图样萎缩:临床及遗传特征
转换为阿柏西普8毫克治疗新生血管性年龄相关性黄斑变性后的初始反应
J Clin Med. 2025 Jul 8;14(14):4824. doi: 10.3390/jcm14144824.
4
Aqueous Humor Cytokine Analysis in Age-Related Macular Degeneration After Switching From Aflibercept to Faricimab.年龄相关性黄斑变性患者转换为 faricimab 治疗后房水细胞因子分析
Invest Ophthalmol Vis Sci. 2024 Sep 3;65(11):15. doi: 10.1167/iovs.65.11.15.
5
Targeting the Tie-2 Receptor With Faricimab in Central Serous Chorioretinopathy: A Case Series Motivated by a Genetic Finding.用法西单抗靶向 Tie-2 受体治疗中心性浆液性脉络膜视网膜病变:基于一项基因发现的病例系列研究
Am J Ophthalmol. 2025 Jan;269:246-254. doi: 10.1016/j.ajo.2024.08.040. Epub 2024 Sep 2.
6
One-year outcomes and safety assessment of faricimab in treatment-naïve patients with neovascular age-related macular degeneration in Japan.在日本,治疗初治的新生血管性年龄相关性黄斑变性患者中 faricimab 的一年疗效和安全性评估。
Sci Rep. 2024 May 22;14(1):11681. doi: 10.1038/s41598-024-62559-1.
7
Factors Associated with Success of Switching to Faricimab for Neovascular Age-Related Macular Degeneration Refractory to Intravitreal Aflibercept.与玻璃体腔注射阿柏西普难治的新生血管性年龄相关性黄斑变性转换为注射法西单抗治疗成功相关的因素。
Life (Basel). 2024 Apr 4;14(4):476. doi: 10.3390/life14040476.
8
One-year visual and anatomical outcomes of intravitreal faricimab injection for neovascular age-related macular degeneration after prior brolucizumab treatment.既往贝伐珠单抗治疗后玻璃体内法西单抗注射治疗新生血管性年龄相关性黄斑变性的 1 年视力和解剖学结果。
Sci Rep. 2024 Apr 20;14(1):9087. doi: 10.1038/s41598-024-59894-8.
9
Qualitative and quantitative comparisons of type 1 macular neovascularizations between pachychoroid neovasculopathy and neovascular age-related macular degeneration using optical coherence tomography angiography.应用光相干断层扫描血管造影术对厚脉络膜新生血管与新生血管性年龄相关性黄斑变性 1 型黄斑新生血管进行定性和定量比较。
Eye (Lond). 2024 Jun;38(9):1714-1721. doi: 10.1038/s41433-024-03007-2. Epub 2024 Mar 12.
10
Short-Term Outcomes of 3 Monthly intravitreal Faricimab On Different Subtypes of Neovascular Age-Related Macular Degeneration.每3个月玻璃体内注射法西单抗治疗不同亚型新生血管性年龄相关性黄斑变性的短期结局
Clin Ophthalmol. 2024 Feb 20;18:507-516. doi: 10.2147/OPTH.S448507. eCollection 2024.
Ophthalmol Retina. 2018 Apr;2(4):295-305. doi: 10.1016/j.oret.2017.08.016. Epub 2017 Nov 22.
4
Association between Choroidal Thickness and Drusen Subtypes in Age-Related Macular Degeneration.年龄相关性黄斑变性中脉络膜厚度与玻璃膜疣亚型之间的关联
Ophthalmol Retina. 2018 Dec;2(12):1196-1205. doi: 10.1016/j.oret.2018.06.014. Epub 2018 Aug 29.
5
Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment.新生血管性年龄相关性黄斑变性:雷珠单抗治疗反应不佳者眼内炎性细胞因子
Clin Ophthalmol. 2018 Sep 26;12:1877-1885. doi: 10.2147/OPTH.S171636. eCollection 2018.
6
Cytokine profiles in the aqueous humor and serum of patients with dry and treated wet age-related macular degeneration.干型和治疗湿性年龄相关性黄斑变性患者房水和血清中的细胞因子谱。
PLoS One. 2018 Aug 29;13(8):e0203337. doi: 10.1371/journal.pone.0203337. eCollection 2018.
7
Distinct Aqueous Humour Cytokine Profiles of Patients with Pachychoroid Neovasculopathy and Neovascular Age-related Macular Degeneration.特发性脉络膜新生血管病和新生血管性年龄相关性黄斑变性患者房水细胞因子特征分析。
Sci Rep. 2018 Jul 12;8(1):10520. doi: 10.1038/s41598-018-28484-w.
8
Pachychoroid disease.脉络膜增厚性疾病。
Eye (Lond). 2019 Jan;33(1):14-33. doi: 10.1038/s41433-018-0158-4. Epub 2018 Jul 11.
9
Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration.阿柏西普治疗延长方案用于厚脉络膜新生血管病变和1型新生血管性年龄相关性黄斑变性的疗效
Jpn J Ophthalmol. 2018 Mar;62(2):144-150. doi: 10.1007/s10384-018-0562-0. Epub 2018 Feb 6.
10
PREVALENCE AND CLINICAL CHARACTERISTICS OF PACHYDRUSEN IN POLYPOIDAL CHOROIDAL VASCULOPATHY: Multimodal Image Study.息肉状脉络膜血管病变中厚壳虫的患病率和临床特征:多模态图像研究。
Retina. 2019 Apr;39(4):670-678. doi: 10.1097/IAE.0000000000002019.